Mammograms may be able to serve another purpose besides detecting breast cancer. The diagnostic tool has been shown to detect calcifications in the blood vessels of patients with advanced kidney disease.

A genetic test may be able to identify those with stage II colon cancer who face a higher risk of recurrence, according to new research from Germany.

Clinical trials under way at four cancer-treatment centers in the U.S. may revolutionize the way the second-leading cause of death in the U.S. is treated.

The American Diabetes Association (ADA) has awarded $600,000 to the Albert Einstein College of Medicine of Yeshiva University to study the effects of resveratrol on prediabetes.

Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.

Glaucoma, a leading cause of blindness in the U.S., may not start in the optic nerve of the eye as previously believed. Researchers indicate the first sign of the disease may appear in the brain.

MIT researchers have discovered that endothelial cells (cells in blood vessels) secrete molecules that inhibit tumor growth and deter cancer cells' invasion of other tissues.

Researchers have revealed how a genetic mutation closely linked to some brain cancers and leukemia may contribute to cancer development.

Swedish researchers have found that damaged alpha-synuclein proteins can spread in Parkinson's disease similar to an infection model found in conditions like mad cow disease.

A new study from the Medical College of Georgia has established a link between fat and chemical changes in DNA. This may explain the increased risk of cardiovascular disease and diabetes among obese individuals.